Results 221 to 230 of about 488,841 (318)

Atypical hyperplasia of the breast--risk assessment and management options.

open access: yesNew England Journal of Medicine, 2015
L. Hartmann   +4 more
semanticscholar   +1 more source

Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic Acids With 225Ac‐ and 177Lu‐Labeled RGD Peptides

open access: yesCancer Science, Volume 117, Issue 1, Page 193-202, January 2026.
Radionuclide therapy using PD‐K(225Ac‐DOTA)‐RGD in BxPC‐3‐bearing mice. PD‐K(225Ac‐DOTA)‐RGD successfully suppressed tumor growth. ABSTRACT Improved peptide pharmacokinetics are needed to enhance the therapeutic effects of peptide‐based radionuclide therapy.
Mitsuyoshi Yoshimoto   +5 more
wiley   +1 more source

Few-shot learning to identify atypical endometrial hyperplasia and endometrial cancer based on transvaginal ultrasonic images

open access: gold
Mingyue Wang   +9 more
openalex   +1 more source

Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy

open access: yesJAMA Oncology, 2017
T. Menes   +5 more
semanticscholar   +1 more source

Prognostic Biomarker of Fertility‐Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial Cancer

open access: yesCancer Science, Volume 117, Issue 1, Page 236-245, January 2026.
We identified prognostic biomarkers that predict treatment outcomes in patients receiving fertility‐preserving high‐dose medroxyprogesterone acetate (MPA) therapy through comprehensive multigene panel testing. ABSTRACT In this study, we identified prognostic biomarkers that predict treatment outcome in patients receiving fertility‐preserving high‐dose ...
Takuro Hirano   +10 more
wiley   +1 more source

Bilateral Primary Lung Carcinomas Associated With Multiple Atypical Adenomatous Hyperplasia

open access: diamond, 2004
Norihiro Kohara   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy